Highlights from the last week in the Biosphere 🌐
BIO Live on BNB Chain
Our new DeSci bridge to BNB is live - making $BIO tradable on @BNBCHAIN via @PancakeSwap, with more Bio ecosystem tokens coming soon.
This lays the groundwork for expanding Bio's ecosystem, launchpad, liquidity layer and x402-enabled Scientific AI Agents to BNB:

➤ BIO token contract address on BNB: 0x226a2fa2556c48245e57cd1cba4c6c9e67077dd2
➤ Stay tuned for upcoming launches on BNB 🔸
BioAgent Deep Research
Our Scientific AI Agent Framework, BioAgents, are evolving their capabilities to perform semi-autonomous biomedical research.
Deep Research has been released and is activated in @Aubrai_, allowing the longevity research agent to perform more comprehensive investigations and serve as a true research co-pilot.
We've been dog-fooding Deep Research with researchers in the Bio Network, while stress-testing its features against the new Scientific AI Benchmarking Framework developed by the Bio AI team.
The release comes on the heels of BioAgents' integration with the x402 protocol, enabling the agents to instantly send and receive USDC micropayments for scientific data and labor.
$AUBRAI holders and researchers with .edu emails can try Deep Research now at https://aubr.ai/.
New DeSci Projects: Ibogaine Therapy, Dog Longevity, Gene-Editing & More
Upcoming DeSci projects launching on Bio:
- DogYears: Canine longevity therapeutics
- Holi: Weights vs Cardio fitness trial testing brain health markers
- Ibonova: Ibogaine therapy for PTSD, using synthetic production
- Drops: Skin longevity serum
- GoCART: Smarter cell therapies for cancer
- VitaSeno: CRISPR gene-editing targeting zombie cells
Recent launches:
- Neuron-Gale - targeting brain inflammation in Alzheimer’s - Project Roadmap
- Foxo3 - RNA therapeutic aimed targeting degenerative disc disease - Project Roadmap
- Relieva - therapeutic cannabis cannabis blend for pain relief
.avif)
DeSci Takeover: Biotech 2.0 Workshop
A new playbook for biotech is emerging: Rapid access to capital, global coordination, and fast R&D cycles with communities giving real-time feedback.
In our latest Researcher Workshop, @shelbynewsad & @0xsmac from @CompoundVC joined Bio CSO @jamessinka to explore Biotech 2.0 and the role DeSci is playing in speeding up science.
➤ Read Compound's article breaking down the DeSci Playbook
➤ Watch a live recording of the workshop from Friday:
Ecosystem
- Curetopia spun out RaptorCo, their first onchain longevity biotech company with $250K seeded. They also shared an ARS pipeline update, with their foundational dataset nearing completion, leading to their second spinout & their first-ever IP-NFT coming soon.
- VitaDAO portfolio project VitaRNA saw its research validated by a new study in published in Nature. According to VitaRNA founder @Mykalt45, the study puts numbers VitaRNA's approach to targeting nonsense mutations in stem and immune cells.
- MicrobiomeDAO conducted the world's first observational study on psychedelics and microbiome interactions, co-facilitated by @psy_dao at the Edge City last month.
- Relieva are currently awaiting the next round round of analysis for their first proprietary medical cannabis strain, showing a 28% CBG-dominant profile.
- SpineDAO laid out its new structure including its commercial arm, Spine AI.
- Pump Science is teaming up with DeSci News for a quest on health & wellness brands to launch on Pump Science.
- MicroDAO unveiled the beta launch of their first product, the Pathogen Catalogue, focused on global pathogen data, research insights, and industry insights. Sign up for the beta.
Community
- Bio founder, Paul Kohlhaas, took the stage at Binance Blockchain Week, exploring the next phase of DeSci, the recent expansion to BNB Chain & what it means for DeSci's evolution.
- We shared the full schedule for DeSci Abu Dhabi, taking place Dec 10, featuring award-winning MIT neuroscientist Ed Boyden, Olympian-turned-enhanced athlete James Magnussen & more. RSVP now.
- @BSCNews covered BIO going live on BNB Chain - asking whether BNB Chain will become a new home for DeSci.
- Paul Kohlhaas discussed how DeSci is evolving from a niche experiment into one of crypto’s most exciting frontiers.
- Bio's podcast, DeSci Pilled, released a new episode with @NootropicsDAO - watch it here.
- DogYears' founder @aitherick published a 90-minute course on the future of DeSci.
Explore New DeSci projects on the Bio App

Stay updated via our Telegram, Discord, Governance forum. Follow @BioProtocolEco on X for real-time ecosystem updates.

.webp)

